Operating Expenses Summary of BioMaxima S.A.

BioMaxima S.A.'s latest annual operating expenses in 2023 was 1.6 Million PLN , down -91.71% from previous year.
BioMaxima S.A.'s latest quarterly operating expenses in 2024 Q2 was 5.4 Million PLN , up 568.23% from previous quarter.
BioMaxima S.A. reported a annual operating expenses of 19.37 Million PLN in annual operating expenses 2022, up 25.86% from previous year.
BioMaxima S.A. reported a annual operating expenses of 15.39 Million PLN in annual operating expenses 2021, up 8.29% from previous year.
BioMaxima S.A. reported a quarterly operating expenses of 5.4 Million PLN for 2024 Q2, up 568.23% from previous quarter.
BioMaxima S.A. reported a quarterly operating expenses of 5.17 Million PLN for 2023 Q3, up 9.65% from previous quarter.

Annual Operating Expenses Chart of BioMaxima S.A. (2023 - 2009)

Historical Annual Operating Expenses of BioMaxima S.A. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	1.6 Million PLN	-91.71%
2022	19.37 Million PLN	25.86%
2021	15.39 Million PLN	8.29%
2020	14.21 Million PLN	16.73%
2019	12.18 Million PLN	-8.01%
2018	13.24 Million PLN	10.18%
2017	12.01 Million PLN	25.61%
2016	9.56 Million PLN	35.67%
2015	7.05 Million PLN	-16.14%
2014	8.41 Million PLN	14.12%
2013	7.36 Million PLN	9.98%
2012	6.7 Million PLN	81.07%
2011	3.7 Million PLN	28.01%
2010	2.89 Million PLN	7.97%
2009	2.67 Million PLN	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	809 Thousand PLN	76.64%
2024 Q2	5.4 Million PLN	568.23%
2023 Q3	5.17 Million PLN	9.65%
2023 FY	1.6 Million PLN	-91.71%
2023 Q1	4.94 Million PLN	59.3%
2023 Q2	4.72 Million PLN	-4.55%
2023 Q4	458 Thousand PLN	-91.16%
2022 FY	19.37 Million PLN	25.86%
2022 Q1	6.79 Million PLN	39.75%
2022 Q2	6.06 Million PLN	-10.87%
2022 Q3	4.54 Million PLN	-24.95%
2022 Q4	3.1 Million PLN	-31.71%
2021 Q4	4.86 Million PLN	33.4%
2021 Q1	3.88 Million PLN	-8.34%
2021 Q2	4.37 Million PLN	12.69%
2021 FY	15.39 Million PLN	8.29%
2021 Q3	3.64 Million PLN	-16.68%
2020 Q4	4.23 Million PLN	25.17%
2020 Q2	3.52 Million PLN	14.96%
2020 Q1	3.06 Million PLN	-4.77%
2020 FY	14.21 Million PLN	16.73%
2020 Q3	3.38 Million PLN	-4.02%
2019 FY	12.18 Million PLN	-8.01%
2019 Q1	2.97 Million PLN	-21.26%
2019 Q2	3.1 Million PLN	4.61%
2019 Q3	2.88 Million PLN	-7.27%
2019 Q4	3.22 Million PLN	11.83%
2018 Q2	2.95 Million PLN	-0.6%
2018 FY	13.24 Million PLN	10.18%
2018 Q1	2.97 Million PLN	-18.68%
2018 Q3	3.53 Million PLN	19.54%
2018 Q4	3.77 Million PLN	6.68%
2017 FY	12.01 Million PLN	25.61%
2017 Q2	2.93 Million PLN	6.46%
2017 Q1	2.75 Million PLN	-34.56%
2017 Q4	3.65 Million PLN	30.57%
2017 Q3	2.8 Million PLN	-4.56%
2016 Q1	1.8 Million PLN	-2.42%
2016 Q4	4.21 Million PLN	137.89%
2016 Q3	1.77 Million PLN	0.73%
2016 Q2	1.75 Million PLN	-2.6%
2016 FY	9.56 Million PLN	35.67%
2015 Q2	1.82 Million PLN	11.43%
2015 FY	7.05 Million PLN	-16.14%
2015 Q1	1.63 Million PLN	-10.41%
2015 Q4	1.85 Million PLN	6.38%
2015 Q3	1.73 Million PLN	-4.66%
2014 Q3	2.26 Million PLN	1.29%
2014 Q2	2.23 Million PLN	7.63%
2014 Q1	2.07 Million PLN	429.6%
2014 Q4	1.82 Million PLN	-19.35%
2014 FY	8.41 Million PLN	14.12%
2013 Q3	2.77 Million PLN	55.21%
2013 Q4	-630.7 Thousand PLN	-122.75%
2013 FY	7.36 Million PLN	9.98%
2013 Q1	1.63 Million PLN	-53.67%
2013 Q2	1.78 Million PLN	9.04%
2012 Q1	884.37 Thousand PLN	0.0%
2012 FY	6.7 Million PLN	81.07%
2012 Q2	851.59 Thousand PLN	-3.71%
2012 Q4	3.53 Million PLN	235.29%
2012 Q3	1.05 Million PLN	23.8%
2011 FY	3.7 Million PLN	28.01%
2010 FY	2.89 Million PLN	7.97%
2009 FY	2.67 Million PLN	0.0%

Peer Operating Expenses Comparison of BioMaxima S.A.

Name	Operating Expenses	Operating Expenses Difference
Scope Fluidics S.A.	2.41 Million PLN	33.361%
Selvita S.A.	12.48 Million PLN	87.137%
Voxel S.A.	27.62 Million PLN	94.187%

Global Stocks Search

BioMaxima S.A. (BMX.WA)

Operating Expenses Summary of BioMaxima S.A.

Annual Operating Expenses Chart of BioMaxima S.A. (2023 - 2009)

Historical Annual Operating Expenses of BioMaxima S.A. (2023 - 2009)

Peer Operating Expenses Comparison of BioMaxima S.A.